Platelet-rich Plasma and Its Application in Clinical Trial
Pham Thi Thanh,Nguyen Thi Mai,Nguyen Thi Ngoc Ha,Mai Thi Hien,Nguyen Dac Tu
DOI: https://doi.org/10.25073/2588-1132/vnumps.4346
2021-09-21
Abstract:Platelet-rich plasma (PRP) is an autologous physiological product that has a platelet concentration above baseline. The PRP contains a high level of important growth factors and cytokines such as PDGF, EGF, VEGF, TGF-β,... which play important roles in healing and tissue regeneration. The PRP is currently used in various medical fields, including orthopedic, plastic surgery, dermatology, dentistry, musculoskeletal and obstetrics-gynecology. To date, the results from in vitro, in vivo studies to clinical trials have proved the effectiveness of PRP in the treating of many diseases. Altogether, PRP is considered to be a very promising futuristic therapy by dint of its simple and highly potential clinical application.
Keywords: Platelet-rich plasma, PRP, growth factors, applications of platelet-rich plasma.
References
[1] J. S. F. Moure, J. L. V. Eps, F. J. Cabrera, Z. Barbosa, G. M. D. Rosal, B. K. Weiner, et al., Platelet-rich Plasma: A Biomimetic Approach to Enhancement of Surgical Wound Healing, Journal of Surgical Research, Vol. 207, No., 2017, pp. 33-44, https://doi.org/10.1016/j.jss.2016.08.063.[2] A. Zarbock, R. K. P. Grabowska, K. Ley, Platelet-neutrophil-interactions: Linking Hemostasis and Inflammation, Blood Reviews, Vol. 21, No. 2, 2007, pp. 99-111, https://doi.org/10.1016/j.blre.2006.06.001.[3] R. E. Marx, Platelet-rich Plasma (PRP): what is PRP and what is not PRP?, Implant Dentistry, Vol. 10, No. 4, 2001, pp. 225-228, https://doi.org/10.1097/00008505-200110000-00002.[4] R. Alves, R. Grimalt, A Review of Platelet-Rich Plasma: History, Biology, Mechanism of Action, and Classification, Skin Appendage Disord, Vol. 4, No. 1, 2018, pp. 18-24, https://doi.org/10.1159/000477353.[5] P. A. Everts, J. T. Knape, G. Weibrich, J. P. Schonberger, J. Hoffmann, E. P. Overdevestet al., Platelet-rich Plasma and Platelet Gel: A Review, The Journal of ExtraCorporeal Technology, Vol. 38, No. 2, 2006, pp. 174-187.[6] A. Mishra, J. W. Jr, A. Vieira, Treatment of Tendon and Muscle Using Platelet-rich Plasma, Clinics in Sports Medicine, Vol. 28, No. 1, 2009, pp. 113-125, https://doi.org/10.1016/j.csm.2008.08.007.[7] R. Dhurat, M. Sukesh, Principles and Methods of Preparation of Platelet-rich Plasma: A Review and Author's Perspective, Journal of Cutaneous Aesthetic Surgery, Vol. 7, No. 4, 2014, pp. 189-197, https://doi.org/10.4103/0974-2077.150734.[8] B. L. Eppley, W. S. Pietrzak, M. Blanton, Platelet-rich Plasma: A Review of Biology and Applications in Plastic Surgery, Plastic and Reconstructive Surgery, Vol. 118, No. 6, 2006, pp. 147e-159e, https://doi.org/10.1097/01.prs.0000239606.92676.cf.[9] K. Mautner, G. Malanga, R. Colberg, Optimization of Ingredients, Procedures and Rehabilitation for Platelet-rich Plasma Injections for Chronic Tendinopathy, Pain Management, Vol. 1, No. 6, 2011, pp. 523-532, https://doi.org/10.2217/pmt.11.56.[10] C. Kia, J. Baldino, R. Bell, A. Ramji, C. Uyeki, A. Mazzocca, Platelet-rich Plasma: Review of Current Literature on its Use for Tendon and Ligament Pathology, Current Reviews in Musculoskeletal Medicine, Vol. 11, No. 4, 2018, pp. 566-572, https://doi.org/10.1007/s12178-018-9515-y.[11] J. Alsousou, M. Thompson, P. Hulley, A. Noble, K. Willett, The Biology of Platelet-rich Plasma and its Application in Trauma and Orthopaedic Surgery: A Review of The Literature, The Journal of Bone and Joint Surgery British volume, Vol. 91, No. 8, 2009, pp. 987-996, https://doi.org/10.1302/0301-620X.91B8.22546.[12] W. J. Berghoff, W. S. Pietrzak, R. D. Rhodes, Platelet-rich Plasma Application During Closure Following Total Knee Arthroplasty, Orthopedics, Vol. 29, No. 7, 2006, pp. 590-598, https://doi.org/10.3928/01477447-20060701-11.[13] D. R. Knighton, K. F. Ciresi, V. D. Fiegel, L. L. Austin, E. L. Butler, Classification and Treatment of Chronic Nonhealing Wounds. Successful Treatment with Autologous Platelet-derived Wound Healing Factors (PDWHF), Annals of Surgery, Vol. 204, No. 3, 1986, pp. 322-330, https://doi.org/10.1097/00000658-198609000-00011.[14] N. N. Tuan, N. T. Dung, Studying the Effects of Platelet-rich Plasma and Adipose Tissue-derived Stem cells on Chronic Wound Treatment, Journal of Disaster Medicine and Burn Injuries, Vol. 5, 2018 (in Vietnamese).[15] D. M. Dohan Ehrenfest, T. Bielecki, A. Mishra, P. Borzini, F. Inchingolo, G. Sammartino et al., in Search of A Consensus Terminology in The Field of Platelet Concentrates for Surgical Use: Platelet-rich Plasma (PRP), Platelet-rich Fibrin (PRF), Fibrin Gel Polymerization and Leukocytes, Current Pharmaceutical Biotechnology, Vol. 13, No. 7, 2012, pp. 1131-1137, https://doi.org/10.2174/138920112800624328.[16] D. H. Whitman, R. L. Berry, D. M. Green, Platelet Gel: An Autologous Alternative to Fibrin Glue with Applications in Oral and Maxillofacial Surgery, Journal of Oral Maxillofacial Surgery, Vol. 55, No. 11, 1997, pp. 1294-1299, https://doi.org/10.1016/s0278-2391(97)90187-7.[17] P. A. Mooar, M. J. Gardner, P. R. Klepchick, The Efficacy of Autologous Platelet Gel in Total Knee Arthroplasty: An Analysis of Range of Motion, Hemoblobin, and Narcotic Requirements, In: 67th Annual Meeting. American Academy of Orthopaedic Surgeons, 2000.[18] T. M. Bielecki, T. S. Gazdzik, J. Arendt, T. Szczepanski, W. Krol, T. Wielkoszynski, Antibacterial Effect of Autologous Platelet Gel Enriched with Growth Factors and Other Active Substances: An in Vitro Study, The Journal of Bone and Joint Surgery British volume, Vol. 89, No. 3, 2007, pp. 417-420, https://doi.org/10.1302/0301-620X.89B3.18491.[19] D. J. Moojen, P. A. Everts, R. M. Schure, E. P. Overdevest, A. V. Zundert, J. T. Knape et al., Antimicrobial Activity of Platelet-leukocyte Gel Against Staphylococcus Aureus, Journal of Orthopaedic Research, Vol. 26, No. 3, 2008, pp. 404-410, https://doi.org/10.1002/jor.20519.[20] D. M. D. Ehrenfest, L. Rasmusson, T. Albrektsson, Classification of Platelet Concentrates: from Pure Platelet-rich Plasma (P-PRP) to Leucocyte- and Platelet-rich Fibrin (L-PRF), Trends in Biotechnology, Vol. 27, No. 3, 2009, pp. 158-167, https://doi.org/10.1016/j.tibtech.2008.11.009.[21] R. E. Marx, E. R. Carlson, R. M. Eichstaedt, S. R. Schimmele, J. E. Strauss, K. R. Georgeff, Platelet-rich Plasma: Growth Factor Enhancement for Bone Grafts, Oral Surgery Oral Medicine Oral Pathology Oral Radiology, Vol. 85, No. 6, 1998, pp. 638-646, https://doi.org/10.1016/s1079-2104(98)90029-4.[22] R. Alissa, M. Esposito, K. Horner, R. Oliver, The Influence of Platelet-rich Plasma on The Healing of Extraction Sockets: An Explorative Randomised Clinical Trial, European Journal of Oral Implantology, Vol. 3, No. 2, 2010, pp. 121-134.[23] R. C. Mariano, W. M. D. Melo, C. C. Avelino, Comparative Radiographic Evaluation of Alveolar Bone Healing Associated with Autologous Platelet-rich Plasma After Impacted Mandibular Third Molar Surgery, Journal of Oral and Maxillofacial Surgery, Vol. 70, No. 1, 2012, pp. 19-24, https://doi.org/10.1016/j.joms.2011.03.028.[24] C. Bacci, M. Maglione, L. Favero, A. Perini, R. D. Lenarda, M. Berengo et al., Management of Dental Extraction in Patients Undergoing Anticoagulant Treatment. Results From A Large, Multicentre, Prospective, Case-control Study, Journal of Thrombosis and Haemostasis, Vol. 104, No. 5, 2010, pp. 972-975, https://doi.org/10.1160/TH10-02-0139.[25] E. Anitua, M. Sanchez, A. T. Nurden, M. Zalduendo, M. D. L. Fuente, J. Azofra et al., Reciprocal Actions of Platelet-secreted TGF-beta1 on The Production of VEGF and HGF by Human Tendon Cells, Plastic and Reconstructive Surgery, Vol. 119, No. 3, 2007, pp. 950-959, https://doi.org/10.1097/01.prs.0000255543.43695.1d.[26] B. O'Connell, N. M. Wragg, S. L. Wilson, The Use of PRP Injections in The Management of Knee Osteoarthritis, Cell and Tissue Research, Vol. 376, No. 2, 2019, pp. 143-152, https://doi.org/10.1007/s00441-019-02996-x.[27] M. A. S. Mendia, J. F. V. Cavazos, H. G. M. Rodriguez, Platelet-rich Plasma in Knee Osteoarthritis Treatment, Cirugia y Cirujanos, Vol. 83, No. 4, 2015, pp. 352-358, https://doi.org/10.1016/j.circir.2014.06.001.[28] H. H. E. Hadmed, R. F. Castillo, Cosmeceuticals: Peptides, Proteins, and Growth Factors, Journal of Cosmetic Dermatology, Vol. 15, No. 4, 2016, pp. 514-519, https://doi.org/10.1111/jocd.12229.[29] D. H. Kim, Y. J. Je, C. D. Kim, Y. H. Lee, Y. J. Seo, J. H. Lee et al., Can Platelet-rich Plasma Be Used for Skin Rejuvenation? Evaluation of Effects of Platelet-rich Plasma on Human Dermal Fibroblast, Annals of Dermatology, Vol. 23, No. 4, 2011, pp. 424-431, https://doi.org/10.5021/ad.2011.23.4.424.[30] N. Cameli, M. Mariano, I. Cordone, E. Abril, S. Masi, M. L. Foddai, Autologous Pure Platelet-Rich Plasma Dermal Injections for Facial Skin Rejuvenation: Clinical, Instrumental, and Flow Cytometry Assessment, Dermatologic Surgery, Vol. 43, No. 6, 2017, pp. 826-835, https://doi.org/10.1097/DSS.0000000000001083.[31] O. K. Abuaf, H. Yildiz, H. Baloglu, M. E. Bilgili, H. A. Simsek, B. Dogan, Histologic Evidence of New Collagen Formulation Using Platelet Rich Plasma in Skin Rejuvenation: A Prospective Controlled Clinical Study, Annals of Dermatology, Vol. 28, No. 6, 2016, pp. 718-724, https://doi.org/10.5021/ad.2016.28.6.718.[32] N. Y. Elnehrawy, Z. A. Ibrahim, A. M. Eltoukhy, H. M. Nagy, Assessment of the Efficacy and Safety of Single Platelet-rich Plasma Injection on Different Types and Grades of Facial Wrinkles, Journal of Cosmetic Dermatology, Vol. 16, No. 1, 2017, pp. 103-111, https://doi.org/10.1111/jocd.12258.[33] B. Hersant, M. S. Mezi, J. Niddam, S. L. Padula, W. Noel, K. Ezzedine et al., Efficacy of Autologous Platelet-rich Plasma Combined with Hyaluronic Acid on Skin Facial Rejuvenation: A Prospective Study, Journal of the American Academy of Dermatology, Vol. 77, No. 3, 2017, pp. 584-586, https://doi.org/10.1016/j.jaad.2017.05.022.[34] Z. A. Ibrahim, R. A. E. Tatawy, M. A. E. Samongy, D. A. Ali, Comparison Between The Efficacy and Safety of Platelet-rich Plasma vs. Microdermabrasion in the Treatment of Striae Distensae: Clinical and Histopathological Study, Journal of Cosmetic Dermatology, Vol. 14, No. 4, 2015, pp. 336-346, https://doi.org/10.1111/jocd.12160.[35] A. Tuknayat, G. P. Thami, M. Bhalla, J. K. Sandhu, Autologous Intralesional Platelet-rich Plasma Improves Melasma, Dermatologic Therapy, Vol. 34, No. 2, 2021, pp. e14881, https://doi.org/10.1111/dth.14881.[36] V. Cervelli, F. Nicoli, D. Spallone, S. Verardi, R. Sorge, M. Nicoli et al., Treatment of Traumatic Scars Using Fat Grafts Mixed with Platelet-rich Plasma, and Resurfacing of Skin with The 1540 nm Nonablative Laser, Clinical and Experimental Dermatology, Vol. 37, No. 1, 2012, pp. 55-61, https://doi.org/10.1111/j.13652230.2011.04199.x.[37] A. C. Nita, O. A. Orzan, M. Filipescu, D. Jianu, Fat Graft, Laser CO(2) and Platelet-rich Plasma Synergy in Scars Treatment, Journal of Medicine and Life, Vol. 6, No. 4, 2013, pp. 430-433.[38] R. James, R. Chetry, V. Subramanian, A. Ashtekar, N. Srikruthi, S. Ramachandran et al., Efficacy of Activated 3X Platelet-Rich Plasma in the Treatment of Androgenic Alopecia, Journal of Stem Cells, Vol. 11, No. 4, 2016, pp. 191-199.[39] R. Alves, R. Grimalt, Randomized Placebo-Controlled, Double-Blind, Half-Head Study to Assess the Efficacy of Platelet-rich Plasma on the Treatment of Androgenetic Alopecia, Dermatologic Surgery, Vol. 42, No. 4, 2016, pp. 491-497, https://doi.org/10.1097/DSS.0000000000000665.[40] C. E. Finch, The Menopause and Aging, A Comparative Perspective, The Journal of Steroid Biochemistry and Molecular Biology, Vol. 142, No., 2014, pp. 132-141, https://doi.org/10.1016/j.jsbmb.2013.03.010.[41] Y. Chang, J. Li, Y. Chen, L. Wei, X. Yang, Y. Shi et al., Autologous Platelet-rich Plasma Promotes Endometrial Growth and Improves Pregnancy Outcome During In Vitro Fertilization, International Journal of Clinical and Experimental Medicine, Vol. 8, No. 1, 2015, pp. 1286-1290.[42] S. Zadehmodarres, S. Salehpour, N. Saharkhiz, L. Nazari, Treatment of Thin Endometrium with Autologous Platelet-rich Plasma: A Pilot Study, JBRA Assisted Reproduction, Vol. 21, No. 1, 2017, pp. 54-56, https://doi.org/10.5935/1518-0557.20170013.[43] Y. Chang, J. Li, L. N. Wei, J. Pang, J. Chen, X. Liang, Autologous Platelet-rich Plasma Infusion Improves Clinical Pregnancy Rate in Frozen Embryo Transfer Cycles for Women with Thin Endometrium, Medicine (Baltimore), Vol. 98, No. 3, 2019, https://doi.org/10.1097/MD.0000000000014062.[44] S. R. Tandulwadkar, M. V. Naralkar, A. D. Surana, M. Selvakarthick, A. H. Kharat, Autologous Intrauterine Platelet-Rich Plasma Instillation for Suboptimal Endometrium in Frozen Embryo Transfer Cycles: A Pilot Study, Journal of Human Reproductive Sciences, Vol. 10, No. 3, 2017, pp. 208-212, https://doi.org/10.4103/jhrs.JHRS_28_17.[45] A. Molina, J. Sanchez, W. Sanchez, V. Vielma, Platelet-rich Plasma As An Adjuvant in the Endometrial Preparation of Patients with Refractory Endometrium, JBRA Assisted Reproduction, Vol. 22, No. 1, 2018, pp. 42-48, https://doi.org/10.5935/1518-0557.20180009.[46] K. Pantos, N. Nitsos, G. Kokkali, T. Vaxevanoglou, C. Markomichali, A. Pantou, Ovarian Rejuvenation and Folliculogenesis Reactivation in Peri-menopausal Women After Autologous Platelet-rich Plasma Treatment, in Proceedings of the 32nd Annual Meeting of ESHRE, Helsinki, Finland, 2016.[47] K. Pantos, M. Simopoulou, A. Pantou, A. Rapani, P. Tsioulou, N. Nitsos, et al., A Case Series on Natural Conceptions Resulting in Ongoing Pregnancies in Menopausal and Prematurely Menopausal Women Following Platelet-rich Plasma Treatment, Cell Transplant, Vol. 28, No. 9-10, 2019, pp. 1333-1340, https://doi.org/10.1177/0963689719859539.[48] J. Fanning, L. Murrain, R. Flora, T. Hutchings, J. M. Johnson, B. W. Fenton, Phase I/II Prospective Trial of Autologous Platelet Tissue Graft in Gynecologic Surgery, Journal of Minimally Invasive Gynecology, Vol. 14, No. 5, 2007, pp. 633-637, https://doi.org/10.1016/j.jmig.2007.05.014.[49] X. Hua, Y. Zeng, R. Zhang, H. Wang, J. Diao, P. Zhang, Using Platelet-rich Plasma for the Treatment of Symptomatic Cervical Ectopy, International Journal of Gynaecology & Obstetrics, Vol. 119, No. 1, 2012, pp. 26-29, https://doi.org/10.1016/j.ijgo.2012.05.029.[50] F. B. Willison, N. R. Pour, B. Mohamadi, N. Willison, M. Rock, I. W. Holten et al., Use of Platelet-rich Plasma for Vulvovaginal Autoimmune Conditions Like Lichen Sclerosus, Plastic and Reconstructive Surgery Global Open, Vol. 4, No. 11, 2016, pp. e1124, https://doi.org/10.1097/GOX.0000000000001124.[51] M. Morelli, M. L. Rocca, R. Venturella, A. D. Cello, S. D. Negro, M. Condorelli et al., Adjuvant Use of Platelet Gel for Wound Breakdown Prevention in Advanced Vulvar Cancer Surgery: A Retrospective Study, International Journal of Gynecological Cancer, Vol. 23, No. 8, 2013, pp. 1490-1494, https://doi.org/10.1097/IGC.0b013e3182a50517.[52] B. B. Adler, E. Hanzal, E. Pablik, H. Koelbl, K. Bodner, Management of Vesicovaginal Fistulas (VVFs) in Women Following Benign Gynaecologic Surgery: A Systematic Review and Meta-analysis, PLoS One, Vol. 12, No. 2, 2017, pp. e0171554, https://doi.org/10.1371/journal.pone.0171554.[53] A. S. Plachokova, J. V. D. Dolder, P. J. Stoelinga, J. A. Jansen, The Bone Regenerative Effect of Platelet-rich Plasma in Combination with An Osteoconductive Material in Rat Cranial Defects, Clinical Oral Implants Research, Vol. 17, No. 3, 2006, pp. 305-311, https://doi.org/10.1111/j.1600-0501.2005.01208.x.[54] A. S. Plachokova, J. V. D. Dolder, P. J. Stoelinga, J. A. Jansen, Early Effect of Platelet-rich Plasma on Bone Healing in Combination with An Osteoconductive Material in Rat Cranial Defects, Clinical Oral Implants Research, Vol. 18, No. 2, 2007, pp. 244-251, https://doi.org/10.1111/j.1600-0501.2006.01327.x.[55] B. H. Choi, C. J. Im, J. Y. Huh, J. J. Suh, S. H. Lee, Effect of Platelet-rich Plasma on Bone Regeneration in Autogenous Bone Graft, International Journal of Oral Maxillofacial Surgery, Vol. 33, No. 1, 2004, pp. 56-59, https://doi.org/10.1054/ijom.2003.0466.[56] B. L. Walters, D. A. Porter, S. J. Hobart, B. B. Bedford, D. E. Hogan, M. M. McHugh et al., Effect of Intraoperative Platelet-Rich Plasma Treatment on Postoperative Donor Site Knee Pain in Patellar Tendon Autograft Anterior Cruciate Ligament Reconstruction: A Double-Blind Randomized Controlled Trial, The American Journal of Sports Medicine, Vol. 46, No. 8, 2018, pp. 1827-1835, https://doi.org/10.1177/0363546518769295.[57] G. E. Niazi, M. S. Hassan, D. M. Elfawy, Ultrasound-guided Injection of Platelet-rich Plasma (PRP) in Rotator Cuff Tendinopathy: Effect on Patients’ Symptoms and Supraspinatus Tendon Thickness, Egyptian Journal of Radiology and Nuclear Medicine, Vol. 51, No. 1, 2020, https://doi.org/ 10.1186/s43055-020-00221-2.[58] L. D. Sante, C. Villani, V. Santilli, M. Valeo, E. Bologna, L. Imparato et al., Intra-articular Hyaluronic Acid vs Platelet-rich Plasma in the Treatment of Hip Osteoarthritis, Medical Ultrasonography, Vol. 18, No. 4, 2016, pp. 463-468, https://doi.org/10.11152/mu-874.[59] J. Wiltfang, K. A. Schlegel, S. S. Mosgau, E. Nkenke, R. Zimmermann, P. Kessler, Sinus Floor Augmentation with Beta-tricalciumphosphate (beta-TCP): Does Platelet-rich Plasma Promote its Osseous Integration and Degradation?, Clinical Oral Implants Research, Vol. 14, No. 2, 2003, pp. 213-218, https://doi.org/10.1034/j.16000501.2003.140212.x.[60] J. H. Wang, X. Nirmala, Application of Tendon Stem/Progenitor Cells and Platelet-Rich Plasma to Treat Tendon Injuries, Operative Techniques in Orthopaedics, Vol. 26, No. 2, 2016, pp. 68-72, https://doi.org/10.1053/j.oto.2015.12.008.[61] H. Toumi, T. M. Best, The Inflammatory Response: Friend or Enemy for Muscle Injury?, British Journal of Sports Medicine, Vol. 37, No. 4, 2003, pp. 284-286, https://doi.org/10.1136/bjsm.37.4.284.[62] C. Smith, M. J. Kruger, R. M. Smith, K. H. Myburgh, The Inflammatory Response to Skeletal Muscle Injury: Illuminating Complexities, Sports Medicine, Vol. 38, No. 11, 2008, pp. 947-969, https://doi.org/10.2165/00007256-200838110-00005.
What problem does this paper attempt to address?
-
Platelet-Rich Plasma: Fundamentals and Clinical Applications
Andrew J Sheean,Adam W Anz,James P Bradley
DOI: https://doi.org/10.1016/j.arthro.2021.07.003
Abstract:Platelet-rich plasma (PRP) is perhaps the most widely studied of the biologic therapies, with an ever-growing body of evidence supporting its safety and efficacy in decreasing inflammation and pain and promoting healing in the setting of both nonoperative and operative treatments. PRP is produced by the centrifugation of whole blood, isolating its constituent parts based on their unique densities. These density gradients can be selectively harvested so as to obtain different concentrations of various blood product components, such as platelets and leukocytes. A precise and consistent method for describing the essential characteristics of different PRP formulations is critical for both practical and research purposes. The concentration of platelets, method of activation, and the total number of red blood cells (RBCs), white blood cells (WBCs), and neutrophils relative to baseline values are all of particular importance in accurately describing a PRP formulation. The biologic activity of PRP is manifold: platelet α granules promote the release of various growth factors, including vascular endothelial growth factor and tissue growth factor β, while inflammation is modulated through inhibition of the nuclear factor-κB pathway. PRP has been convincingly shown to be efficacious in the setting of patellar tendinopathies, knee osteoarthritis, and lateral epicondylitis. In fact, several recent randomized controlled trials have demonstrated the superiority of PRP over both corticosteroids and hyaluronic acid in treating knee OA-related symptoms. There is also substantial promise for the utility of PRP in treating partial hamstring tears and as an adjunct to rotator cuff (RC) repair, especially in the setting of small- to medium-sized tears, where it appears to exert substantial analgesic effects and promote enhanced rates of RC repair healing.
-
Platelet Rich Plasma in Orthopedic Surgical Medicine.
Peter A. Everts,Albert van Erp,Alfred DeSimone,Dan S. Cohen,Ronald D. Gardner
DOI: https://doi.org/10.1080/09537104.2020.1869717
2021-01-05
Platelets
Abstract:<span>There is a global interest in optimizing post-surgical tissue repair strategies, leading to better patient outcomes and fewer complications, most ideally with reduced overall cost. In this regard, in recent years, the interest in autologous biological treatments in orthopedic surgery and sports medicine has increased greatly, and the addition of platelet-rich plasma (PRP) to the surgical armamentarium is of particular note. Unfortunately, the number of PRP preparation devices has also grown immensely over the recent decades, raising meaningful concern for the considerable variation in the qualities of currently available PRP preparations. The lack of consensus on the standardization of PRP preparation and of agreement on condition specific PRP formulations is largely responsible for the sometimes contradictory outcomes in the literature. Furthermore, the full potential of PRP technology, the concept of individualized treatment protocols based on bioformulation options, and platelet dosing, angiogenesis, and antimicrobial and painkilling effects of PRP relevant to orthopedic surgery have rarely been addressed. In this review, we will discuss recent developments regarding PRP preparations and potential therapeutic effects. Additionally, we present a synopsis of several published data regarding PRP applications in orthopedic surgery for treating tendon injuries, inducing bone repair, strengthening spinal fusion outcomes, and supporting major joint replacements.</span>
cell biology,hematology
-
Efficacy of platelet-rich plasma for non-transfusion use: Overview of systematic reviews
Daniela Vianna Pachito,Carolina de Oliveira Cruz Latorraca,Rachel Riera
DOI: https://doi.org/10.1111/ijcp.13402
Abstract:Introduction: Platelet-rich plasma (PRP) is a blood component therapy with a supraphysiological concentration of platelets derived from allogenic or, more commonly, autologous blood. PRP has been used in different non-transfusion indications because of its role in the promotion of tissue repair and healing, in fields such as Traumatology, Dermatology and Dentistry. Objective: To provide a synthesis of the efficacy of PRP for different clinical situations. Methods: Systematic searches were carried out in MEDLINE, Embase, Cochrane Library and LILACS in July 2018 to identify systematic reviews (SRs) of randomized clinical trials (RCTs) focusing on PRP for non-transfusion use. Two authors independently screened all retrieved references in two stages (titles and abstracts at a first stage and full texts at a second stage). The methodological quality of SRs that met the eligibility criteria was appraised by AMSTAR 2. Conclusions were based on the most recent SRs with highest quality. Results: One thousand two hundred and forty references were retrieved. After checking the inclusion criteria, 29 SRs of RCTs related to three different fields (wound care, Orthopedics and Dentistry) were included. The results suggest the benefit of PRP for different clinical situations, such as diabetic wounds, acute lesions of musculoskeletal system, rotator cuff lesions, tendinopathies, knee and hip osteoarthritis, total knee arthroplasty, allogenic bone graft for dental implants and periodontal intrabony defects. Conclusion: There is low to moderate quality evidence supporting the efficacy of PRP for specific clinical situations. The low quality of the evidence limits the certainty of these findings. Well-planned and well-conducted RCTs are still needed to further assess the efficacy of PRP.
-
Considerations for the use of platelet-rich plasma in orthopedics
Taralyn M McCarrel,Nathan A Mall,Andrew S Lee,Brian J Cole,Davietta C Butty,Lisa A Fortier
DOI: https://doi.org/10.1007/s40279-014-0195-5
Abstract:The use of platelet-rich plasma (PRP) is expanding to numerous medical fields, including orthopedic surgery and sports medicine. The popularity of this new treatment option has prompted a rapid increase in research endeavors; however, the differences in application technique and the composition of PRP have made it difficult to compare results or make any firm conclusions regarding efficacy. The purpose of this article is twofold. First, to recommend details that should be provided in basic science and clinical PRP studies to allow meaningful comparisons between studies which may lead to a better understanding of efficacy. Second, to provide an understanding of the different PRP preparations and their clinical relevance. There are biochemical rationales for the use of PRP because it addresses several aspects of the healing process, including cell proliferation and tissue matrix regeneration, inflammation, nociception, infection, and hemostasis, all of which will be addressed. Given the current understanding of the importance the composition of PRP plays in tissue regeneration, it is likely that our future understanding of PRP will dictate 'customizing' the PRP preparation to the specific pathology of interest. The potential complications following PRP use are minor, and thus it appears to be a safe treatment option with a variety of potentially beneficial effects to injured musculoskeletal tissues.
-
Platelet-Rich Plasma Therapy in the Treatment of Diseases Associated with Orthopedic Injuries
Jie Fang,Xin Wang,Wen Jiang,Yaqiong Zhu,Yongqiang Hu,Yanxu Zhao,Xueli Song,Jinjuan Zhao,Wenlong Zhang,Jiang Peng,Yu Wang
DOI: https://doi.org/10.1089/ten.TEB.2019.0292
Abstract:Platelet-rich plasma (PRP) is an autologous platelet concentrate prepared from the whole blood that is activated to release growth factors (GFs) and cytokines and has been shown to have the potential capacity to reduce inflammation and improve tissue anabolism for regeneration. The use of PRP provides a potential for repair due to its abundant GFs and cytokines, which are key in initiating and modulating regenerative microenvironments for soft and hard tissues. Among outpatients, orthopedic injuries are common and include bone defects, ligament injury, enthesopathy, musculoskeletal injury, peripheral nerve injury, chronic nonhealing wounds, articular cartilage lesions, and osteoarthritis, which are caused by trauma, sport-related or other types of trauma, or tumor resection. Surgical intervention is often required to treat these injuries. However, for numerous reasons regarding limited regeneration capacity and insufficient blood supply of the defect region, these treatments commonly result in unsatisfactory outcomes, and follow-up treatment is challenging. The aim of the present review is to explore future research in the field of PRP therapy in the treatment of diseases associated with orthopedic injuries. Impact statement In recent years, platelet-rich plasma (PRP) has become widely used in the treatment of diseases associated with orthopedic injuries, and the results of numerous studies are encouraging. Due to diseases associated with orthopedic injuries being common in clinics, as a conservative treatment, more and more doctors and patients are more likely to accept PRP. Importantly, PRP is a biological product of autologous blood that is obtained by a centrifugation procedure to enrich platelets from whole blood, resulting in few complications, such as negligible immunogenicity from an autologous source, and it is also simple to produce through an efficient and cost-effective method in a sterile environment. However, the applicability, advantages, and disadvantages of PRP therapy have not yet been fully elucidated. The aim of the present review is to explore future research in the field of PRP therapy in the treatment of diseases associated with orthopedic injuries, as well as to provide references for clinics.
-
Platelet-Rich Plasma: New Performance Understandings and Therapeutic Considerations in 2020
Peter Everts,Kentaro Onishi,Prathap Jayaram,José Fábio Lana,Kenneth Mautner
DOI: https://doi.org/10.3390/ijms21207794
IF: 5.6
2020-10-21
International Journal of Molecular Sciences
Abstract:Emerging autologous cellular therapies that utilize platelet-rich plasma (PRP) applications have the potential to play adjunctive roles in a variety of regenerative medicine treatment plans. There is a global unmet need for tissue repair strategies to treat musculoskeletal (MSK) and spinal disorders, osteoarthritis (OA), and patients with chronic complex and recalcitrant wounds. PRP therapy is based on the fact that platelet growth factors (PGFs) support the three phases of wound healing and repair cascade (inflammation, proliferation, remodeling). Many different PRP formulations have been evaluated, originating from human, in vitro, and animal studies. However, recommendations from in vitro and animal research often lead to different clinical outcomes because it is difficult to translate non-clinical study outcomes and methodology recommendations to human clinical treatment protocols. In recent years, progress has been made in understanding PRP technology and the concepts for bioformulation, and new research directives and new indications have been suggested. In this review, we will discuss recent developments regarding PRP preparation and composition regarding platelet dosing, leukocyte activities concerning innate and adaptive immunomodulation, serotonin (5-HT) effects, and pain killing. Furthermore, we discuss PRP mechanisms related to inflammation and angiogenesis in tissue repair and regenerative processes. Lastly, we will review the effect of certain drugs on PRP activity, and the combination of PRP and rehabilitation protocols.
biochemistry & molecular biology,chemistry, multidisciplinary
-
Platelet-rich plasma: a narrative review
Thomas Collins,Dinesh Alexander,Bilal Barkatali
DOI: https://doi.org/10.1302/2058-5241.6.200017
IF: 4.775
2021-04-01
EFORT Open Reviews
Abstract:The aim of this article was to synopsize platelet-rich plasma (PRP) use in musculoskeletal pathologies through evidence-based assessment of the preparation, classification, mechanism of action and applications of PRP, thereby answering which PRP type is best for each clinical indication. The literature search was performed using Medline, EMBASE and Cochrane Reviews databases for papers containing the key terms “platelet-rich plasma” AND “orthopaedics” AND (“classification” OR “mechanism of action” OR “preparation” OR “clinical application”). Generated papers were evaluated for pertinence in following areas: preparation, classification, mechanism of action, clinical application within orthopaedics. Non-English papers were excluded. Included studies were evaluated for quality. Sixty studies were included in our review. There are many commercial PRP preparation kits with differing component concentrations. There is no consensus on optimal component concentrations. Multiple PRP classifications exist but none have been validated. Platelet-rich plasma acts via growth factors (GFs) released from α-granules within platelets. Growth factors have been shown to be beneficial in healing. Grossly elevated concentrations of GFs may have inhibitory effects on healing. Multiple systematic reviews show efficacy of PRP in tendinopathies, early osteoarthritis, acute muscle injuries and in combination with rotator cuff repair and anterior cruciate ligament reconstruction. The literature suggests leukocyte-rich PRP (L-PRP) is more beneficial in tendinopathies and pure PRP (P-PRP) is more beneficial in cartilage pathology. However, different PRP preparations have not been directly compared in any pathology. Classification of PRP type is frequently not stated in research. Standardization of PRP research parameters is needed to streamline findings and generate clear indications for PRP types to yield maximum clinical benefit. Cite this article: EFORT Open Rev 2021;6:225-235. DOI: 10.1302/2058-5241.6.200017
orthopedics
-
The use of platelet-rich plasma in arthroscopy and sports medicine: optimizing the healing environment
Emilio Lopez-Vidriero,Krista A Goulding,David A Simon,Mikel Sanchez,Donald H Johnson
DOI: https://doi.org/10.1016/j.arthro.2009.11.015
Abstract:Platelet-rich plasma (PRP) is a new technology focused on enhancing the healing response after injury of different tissue types. PRP is prepared by withdrawal of patients' peripheral blood and centrifugation to obtain a highly concentrated sample of platelets, which undergo degranulation to release growth factors with healing properties. It also contains plasma, cytokines, thrombin, and other growth factors that are implicated in wound healing and have inherent biological and adhesive properties. The prepared concentrate is then injected back into the patient at the site of morbidity. This may be intralesional, intra-articular, or surrounding the involved tissue bed. PRP preparations have been used therapeutically in various medical fields from implantology to vascular ulcers, with a more recent evolution and promising results in the field of sports medicine and arthroscopy. Sports medicine patients desire a rapid return to their preinjury level of function, and PRP may have certain applications that will speed recovery in cases of tendon, ligament, muscle, and cartilage disorders. In particular, anterior cruciate ligament reconstruction has shown better autograft maturation, improved donor site morbidity, and pain control, in addition to improved allograft incorporation. By acceleration of the biological integration of the graft by use of PRP, patients may undergo faster, more intensive rehabilitation programs and return to sports more rapidly. Because of its autogenous origin, easy preparation, and excellent safety profile, the advent of PRP has opened another therapeutic door for sports medicine physicians and orthopaedic surgeons. Future directions of PRP include improving the results of arthroscopic and related surgery, in addition to delineating correct dosage, timing, and quantification, as well as ideal techniques of PRP application.
-
Biology of Platelet-Rich Plasma and Its Clinical Application in Cartilage Repair
Xuetao Xie,Changqing Zhang,Rocky S Tuan
DOI: https://doi.org/10.1186/ar4493
2014-01-01
Arthritis Research & Therapy
Abstract:Platelet-rich plasma (PRP) is an autologous concentrated cocktail of growth factors and inflammatory mediators, and has been considered to be potentially effective for cartilage repair. In addition, the fibrinogen in PRP may be activated to form a fibrin matrix to fill cartilage lesions, fulfilling the initial requirements of physiological wound healing. The anabolic, anti-inflammatory and scaffolding effects of PRP based on laboratory investigations, animal studies, and clinical trials are reviewed here. In vitro, PRP is found to stimulate cell proliferation and cartilaginous matrix production by chondrocytes and adult mesenchymal stem cells (MSCs), enhance matrix secretion by synoviocytes, mitigate IL-1β-induced inflammation, and provide a favorable substrate for MSCs. In preclinical studies, PRP has been used either as a gel to fill cartilage defects with variable results, or to slow the progression of arthritis in animal models with positive outcomes. Findings from current clinical trials suggest that PRP may have the potential to fill cartilage defects to enhance cartilage repair, attenuate symptoms of osteoarthritis and improve joint function, with an acceptable safety profile. Although current evidence appears to favor PRP over hyaluronan for the treatment of osteoarthritis, the efficacy of PRP therapy remains unpredictable owing to the highly heterogeneous nature of reported studies and the variable composition of the PRP preparations. Future studies are critical to elucidate the functional activity of individual PRP components in modulating specific pathogenic mechanisms.
-
Platelet-rich plasma in orthopaedic applications: evidence-based recommendations for treatment
Wellington K Hsu, Allan Mishra, Scott R Rodeo, Freddie Fu, Michael A Terry, Pietro Randelli, Terry S Canale, Frank B Kelly
2013-12-01
Abstract:Autologous platelet-rich plasma (PRP) therapies have seen a dramatic increase in breadth and frequency of use for orthopaedic conditions in the past 5 years. Rich in many growth factors that have important implications in healing, PRP can potentially regenerate tissue via multiple mechanisms. Proposed clinical and surgical applications include spinal fusion, chondropathy, knee osteoarthritis, tendinopathy, acute and chronic soft-tissue injuries, enhancement of healing after ligament reconstruction, and muscle strains. However, for many conditions, there is limited reliable clinical evidence to guide the use of PRP. Furthermore, classification systems and identification of differences among products are needed to understand the implications of variability.
-
Current Progress of Platelet-Rich Derivatives in Cartilage and Joint Repairs
Meng-Yi Bai,Vu Pham Thao Vy,Sung-Ling Tang,Truong Nguyen Khanh Hung,Ching-Wei Wang,Jui-Yuan Liang,Chin-Chean Wong,Wing P Chan,Wing P. Chan
DOI: https://doi.org/10.3390/ijms241612608
IF: 5.6
2023-08-10
International Journal of Molecular Sciences
Abstract:In recent years, several types of platelet concentrates have been investigated and applied in many fields, particularly in the musculoskeletal system. Platelet-rich fibrin (PRF) is an autologous biomaterial, a second-generation platelet concentrate containing platelets and growth factors in the form of fibrin membranes prepared from the blood of patients without additives. During tissue regeneration, platelet concentrates contain a higher percentage of leukocytes and a flexible fibrin net as a scaffold to improve cell migration in angiogenic, osteogenic, and antibacterial capacities during tissue regeneration. PRF enables the release of molecules over a longer period, which promotes tissue healing and regeneration. The potential of PRF to simulate the physiology and immunology of wound healing is also due to the high concentrations of released growth factors and anti-inflammatory cytokines that stimulate vessel formation, cell proliferation, and differentiation. These products have been used safely in clinical applications because of their autologous origin and minimally invasive nature. We focused on a narrative review of PRF therapy and its effects on musculoskeletal, oral, and maxillofacial surgeries and dermatology. We explored the components leading to the biological activity and the published preclinical and clinical research that supports its application in musculoskeletal therapy. The research generally supports the use of PRF as an adjuvant for various chronic muscle, cartilage, and tendon injuries. Further clinical trials are needed to prove the benefits of utilizing the potential of PRF.
biochemistry & molecular biology,chemistry, multidisciplinary
-
Platelet-rich plasma as a new treatment method in orthopedics
Aleksandra Janocha,Aneta Jerzak,Anna Hitnarowicz,Bożena Kmak,Anna Szot,Agnieszka Pociecha
DOI: https://doi.org/10.12775/jehs.2024.67.49195
2024-05-12
Abstract:Introduction and purposePlatelet-rich plasma (PRP) therapy represents a technology designed to enhance tissue repair by locally administering one's own bioactive agents, aiming to influence physiological processes like inflammation, angiogenesis, and extracellular matrix synthesis. Recently, the use of PRP therapy has become a subject of discussion in the orthopedic field. This review comprehensively examines the mechanisms, contemporary applications, clinical evidence, safety aspects, and potential future advancements of PRP in orthopedic treatment. Research has documented the efficacy of PRP injections in achieving full regeneration and enabling a comeback to competitive sports. PRP injections could serve as a viable alternative treatment for individuals with lateral tendonitis when compared to surgery. Further research investigating the impact of PRP on the bone healing process following a fracture is warranted.
Materials and methods The methodology for conducting literature search involved utilizing medical subject headings terms to explore PubMed. Search terms included: "plasma-rich therapy", "tendinopathy", "injury" " articular cartilage ", "bone fracture "
ConclusionsResearch at different evidence levels has shown that PRP is safe and has beneficial effects in above uses. Due to the autologous nature of the therapy, side effects are minimal. In the majority of cases, PRP therapy alleviates pain sensations in both short- and long-term observations, facilitating a faster return to daily functionality. However, additional randomized, controlled clinical trials are anticipated to be conducted in the future. Progressing further necessitates the standardization of methods for preparing plasma and procedures for its application.
-
Platelet-rich plasma in orthopedics: Bridging innovation and clinical applications for bone repair
Liangbo Zhu,Ping Li,Yuhong Qin,Baowei Xiao,Junning Li,Wenhua Xu,Bo Yu
DOI: https://doi.org/10.1177/10225536231224952
2024-01-15
Journal of Orthopaedic Surgery
Abstract:Journal of Orthopaedic Surgery, Volume 32, Issue 1, January-April 2024. In the burgeoning domain of orthopedic therapeutic research, Platelet-Rich Plasma (PRP) has firmly established its position, transforming paradigms ranging from tissue regeneration to the management of chondral lesions. This review delves into PRP's recent integrations with cutting-edge interventions such as 3D-printed scaffolds, its role in bone and cartilage defect management, and its enhanced efficacy when combined with molecules like Kartogenin (KGN) for fibrocartilage zone repair. Significant attention is paid to tissue engineering for meniscal interventions, where a combination of KGN, PRP, and bone marrow-derived mesenchymal stem cells are under exploration. Within the sphere of osteochondral regenerative therapy, the synergy of PRP with Bone Marrow Aspirate Concentrate (BMAC) represents a noteworthy leap towards cartilage regeneration. The innovative incorporation of PRP with biomaterials like hydroxyapatite and graphene oxide further underscores its versatility in supporting structural integrity and ensuring sustained growth factor release. However, while PRP's autologous and nontoxic nature makes it an inherently safe option, concerns arising from its preparation methods, particularly with bovine thrombin, necessitate caution. As of 2023, despite the burgeoning promise of PRP in bone healing, the quest for its standardization, optimization, and substantiation through rigorous clinical trials continues. This comprehensive review elucidates the contemporary applications, challenges, and future trajectories of PRP in orthopedics, aiming to spotlight areas primed for further research and exploration.
surgery,orthopedics
-
Exploring Platelet-Rich Plasma Therapy for Knee Osteoarthritis: An In-Depth Analysis
Florin Nicolae Blaga,Alexandru Stefan Nutiu,Alex Octavian Lupsa,Nicu Adrian Ghiurau,Silviu Valentin Vlad,Timea Claudia Ghitea
DOI: https://doi.org/10.3390/jfb15080221
2024-08-09
Abstract:The use of platelet-rich plasma (PRP) in all medical fields is currently gaining popularity (1). PRP is a biological product that can be defined as a segment of the plasma fraction of autologous blood with a platelet concentration level above the baseline (2). The fact that it has uses in tissue regeneration and wound healing has caught the eye of orthopedic surgeons as well, as intra-articular treatments have continued to evolve. Its benefits in the treatment of different osteoarticular pathologies are of great interest in the evolving orthopedic community, targeting mostly knee osteoarthritis, meniscus and ligament injuries (3). The purpose of this review is to update the reader on the current uses of platelet-rich plasma (PRP) in the treatment of knee osteoarthritis pathology and to provide clinical feedback on its uses in the fields of orthopedic and sports medicine practice (4). We proceeded in studying 180 titles and abstracts eligible for inclusion. Compared to alternative treatments, PRP injections greatly improve the function of the knee joint.
-
Platelet-rich therapies in the treatment of orthopaedic sport injuries
Mikel Sánchez,Eduardo Anitua,Gorka Orive,Iñigo Mujika,Isabel Andia
DOI: https://doi.org/10.2165/00007256-200939050-00002
Abstract:Biomedical sciences have made major advances in understanding how tissues repair, and the signalling mechanisms required to achieve this goal are progressively being dissected. Advances in the understanding of tissue repair mechanisms and the pivotal role of growth factors have stimulated the use of platelet-rich therapies by orthopaedic surgeons and sports physicians, mainly with the aim of stimulating and enhancing tissue healing. Autologous activated platelets retained in fibrin matrices are used as a source of molecular signals that control cell fate, including cell growth, cell differentiation and the synthesis of diverse functional proteins. Thus far, platelet-rich technologies have spawned additional ambitious endeavours, including surgical and non-surgical treatments in sports orthopaedics. Reconstruction of anterior cruciate ligament and tendon surgery and treatment of joint injuries, tendinopathy or muscle tears are but a few examples of the potential applications of this technology in the field of orthopaedic sports medicine. In the present article, some of the most important therapeutic applications using these approaches - especially preparation rich in growth factor (PRGF) technology - are presented, as are some of the limitations, anti-doping concerns and future challenges in the field. In view of a general state of confusion, the concept of platelet-rich plasma needs rigorous definition associated with well characterized products and re-administration procedures. There is evidence that reconstruction of anterior cruciate ligament and tendon surgery combined with PRGF enhances healing and functional recovery; clinical evidence is also appearing in the literature regarding treatment of tendinopathies and osteoarthritis. Currently, the challenge lies in conducting randomized, controlled clinical trials to determine the essential qualities of these technologies. If anti-doping agencies clarify their regulatory guidelines, robust studies in athletes are expected to emerge. Although much research work lies ahead, the current knowledge points to a future in which platelet-rich therapies will continue improving existing conventional approaches to treatment of sports injuries.
-
Platelets in wound healing and regenerative medicine
Julia Etulain
DOI: https://doi.org/10.1080/09537104.2018.1430357
2018-02-14
Platelets
Abstract:Although platelets are widely recognized as having a critical role in primary hemostasis and thrombosis, increasing experimental and clinical evidence identifies these enucleated cells as relevant modulators of other physiopathological processes including inflammation and tissue regeneration. These phenomena are mediated through the release of growth factors, cytokines, and extracellular matrix modulators that sequentially promote (i) revascularization of damaged tissue through the induction of migration, proliferation, differentiation, and stabilization of endothelial cells in new blood vessels; (ii) restoration of damaged connective tissue through migration, proliferation, and activation of fibroblasts; and (iii) proliferation and differentiation of mesenchymal stem cells into tissue-specific cell types. For these reasons, platelet-rich plasma (PRP) derivatives are used in regenerative medicine for the treatment of several clinical conditions including ulcers, burns, muscle repair, bone diseases, and tissue recovery following surgery. The benefits of PRP administration are associated with an economical advantage, taking into consideration that PRP administration does not require complex equipment or training for its execution. Moreover, due to their primary autologous origin, concerns of disease transmission or immunogenic reactions can be disregarded. Thus, platelet-enriched materials have become highly relevant in the last decade and constitute a growing focus of experimental and clinical study in the context of wound healing and tissue regeneration. However, despite the diverse applications, the efficacy of regenerative treatments using PRP is being called into question due to the lack of large controlled clinical trials and the lack of consensus regarding the PRP preparation techniques. This review describes the biological mechanisms underlying PRP's regenerative effects, the different methods of preparation and application of these biomaterials, and the controversies and future prospects related to the use of PRP in regenerative medicine.
cell biology,hematology
-
The basic science of platelet-rich plasma (PRP): what clinicians need to know
Steven P Arnoczky,Shahin Sheibani-Rad
DOI: https://doi.org/10.1097/JSA.0b013e3182999712
Abstract:Platelet-rich plasma (PRP) has been advocated for the biological augmentation of tissue healing and regeneration through the local introduction of increased levels (above baseline) of platelets and their associated bioactive molecules. In theory, the increased levels of autologous growth factors and secretory proteins provided by the concentrated platelets may enhance the wound healing process, especially in degenerative tissues or biologically compromised individuals. Although PRP has been increasingly utilized in the treatment of a variety of sports-related injuries, improvements in healing and clinical outcomes have not been universally reported. One reason for this may be the fact that all PRP preparations are not the same. Variations in the volume of whole blood taken, the platelet recovery efficacy, the final volume of plasma in which the platelets are suspended, and the presence or absence of white blood cells, and the addition of exogenous thrombin to activate the platelets or calcium chloride to induce fibrin formation, can all affect the character and potential efficacy of the final PRP product. This article will review the basic principles involved in creating PRP and examine the potential basic scientific significance of the individual blood components contained in the various forms of PRP currently used in sports medicine.
-
The use of platelet-rich plasma to treat chronic tendinopathies: A technical analysis
Jean-François Kaux,Thibault Emonds-Alt
DOI: https://doi.org/10.1080/09537104.2017.1336211
2017-07-31
Platelets
Abstract:Platelet-rich plasma (PRP) is blood plasma with a high concentration of autologous platelets which constitute an immense reservoir of growth factors. The clinical use of PRP is widespread in various medical applications. Although highly popular with athletes, the use of PRP for the treatment of tendinopathies remains scientifically controversial, particularly due to the diversity of products that go by the name of "PRP." To optimize its use, it is important to look at the various stages of obtaining PRP. In this literature review, we take a closer look at eight parameters which may influence the quality of PRP: 1) anticoagulants used to preserve the best platelet function, 2) the speed of centrifugation used to extract the platelets, 3) the platelet concentrations obtained, 4) the impact of the concentration of red and while blood cells on PRP actions, 5) platelet activators encouraging platelet degranulation and, hence, the release of growth factors, and 6) the use or nonuse of local anesthetics when carrying out infiltration. In addition to these parameters, it may be interesting to analyze other variables such as 7) the use of ultrasound guidance during the injection with a view to determining the influence they have on potential recovery.
cell biology,hematology
-
Most Publications Regarding Platelet-Rich Plasma Use in the Knee Are From Asia, Investigate Injection for Osteoarthritis, and Show Outcome Improvement: A Scoping Review
Henry B G Baird,Cody C Ashy,Prudhvi Kodali,Gregory D Myer,Iain R Murray,W Michael Pullen,Harris S Slone
DOI: https://doi.org/10.1016/j.arthro.2024.03.030
2024-03-25
Abstract:Purpose: To evaluate and synthesize the available literature related to platelet-rich plasma (PRP) treatment of knee pathologies and to provide recommendations to inform future research in the field. Methods: PubMed, CINAHL, and Scopus databases were queried on October 6, 2023. All identified citations were collated and uploaded into Covidence for screening and data extraction. Studies were included if they were human studies published in English with adult cohorts that received PRP as a procedural injection or surgical augmentation for knee pathologies with patient-reported outcome measures (PROMs) and level of evidence Levels I-IV. Results: Our search yielded 2,615 studies, of which 155 studies from 2006 to 2023 met the inclusion criteria. Median follow-up was 9 months (±11.2 months). Most studies (75.5%) characterized the leukocyte content of PRP, although most studies (86%) did not use a comprehensive classification scheme. In addition, most studies were from Asia (50%) and Europe (32%) and were from a single center (96%). In terms of treatment, 74% of studies examined PRP as a procedural injection, whereas 26% examined PRP as an augmentation. Most studies (68%) examined treatment of knee osteoarthritis. Many studies (83%) documented significant improvements in PROMs, including 93% of Level III/IV evidence studies and 72% of Level I/II evidence studies, although most studies (70%) failed to include minimal clinically important difference values. The visual analog scale was the most-used PROM (58% of studies), whereas the Short Form Health Survey 36-item was the least-used PROM (5% of studies). Conclusions: Most published investigations of knee PRP are performed in Asia, investigate procedural injection for osteoarthritis, and show significant outcome improvements. In addition, this review highlights the need for better classification of PRP formulations. Level of evidence: Level IV, scoping Review of level I-IV studies.
-
Theoretical study and clinical practice of platelet-rich plasma in improving bone repair
Ting Yuan,Chang-qing Zhang,Si-bo Li,Shang-chun Guo,Bing-fang Zeng
DOI: https://doi.org/10.3321/j.issn:1673-8225.2006.05.061
2006-01-01
Abstract:OBJECTIVE: To review the development and mechanism of platelet-rich plasma (PRP) and the unsolved problems so as to provide reference for the clinical application of PRP.DATA SOURCES: Articles on effects of platelet-rich plasma on bone repair are searched from Medline between January 1995 and June 2005 on computer. The key words were platelet rich plasma, bone, and repair.Meanwhile, the same search was conducted to determine the correlated articles during January 1998 to June 2005 from Wanfang database with key words of platelet-rich plasma, bone and repair in Chinese.STUDY SELECTION: Literatures at home and abroad on the PRP and bone repair were chosen; Non-randomized controlled literatures were included.DATA EXTRACTION: Totally 40 out of 49 reports related to PRP and bone repair met the criteria. 9 reports were excluded due to the repeated same research. The rest 40 reports were sorted out and conducted literature review.DATA SYNTHESIS: Platelet-rich plasma was originally used in clinic to repair mandibular defect in 1998, by adding PRP to grafts with a radiographic maturation rate 1.62 to 2.16 times that of grafts without PRP. Up to now, PRP has been used in many medical areas to accelerate tissue healing due to its advantages of safety, simple, low-cost. But some problems still remain to be studied and solved.CONCLUSION: PRP includes many sorts of growth factors and has been proved to be beneficial to the maturation of both bone tissue and soft tissues. PRP is autologous and can be produced easily and safely from autologous blood, without the concerns of transmissions and immunological rejection of various diseases.